Effects of buprenorphine on behavior maintained by heroin and alfentanil in rhesus monkeys

Behavioural Pharmacology

Volumn 7, Issue 2, 1996, Pages 155-159

  Winger, G ^a   Woods, J H ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Alfentanil; Buprenorphine; Heroin; Rhesus monkey; Self administration

Indexed keywords

ALFENTANIL; BUPRENORPHINE; DIAMORPHINE; OPIATE AGONIST; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG MECHANISM; DRUG SELF ADMINISTRATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; REINFORCEMENT; RHESUS MONKEY;

EID: 0029968494     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199603000-00006     Document Type: Article

References (13)

1. Amass L, Bickel WK, Higgins ST and Badger GJ (1994) Alternate-day dosing during buprenorphine treatment of opioid dependence. Life Sciences, 54, 1215-1228.
2. Bickel WK, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR and Johnson RE (1988) Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans. Journal of Pharmacology and Experimental Therapeutics, 247, 47-53.
3. Cowan A, Lewis JW and MacFarlane IR (1977) Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. British Journal of Pharmacology, 60, 537-545.
4. Deneau GA, Yanagita T and Seevers MH (1969) Self-administration of psychoactive substances by the monkey - a measure of psychological dependence. Psychopharmacologia, 16, 30-48.
5. Dykstra LA (1983) Behavioral effects of buprenorphine and diprenorphine under a multiple schedule of food presentation in squirrel monkeys. Journal of Pharmacology and Experimental Therapeutics, 226, 317-323.
6. Kosten TR, Schottenfeld R, Ziedonis D and Falcioni J (1993) Buprenorphine versus methadone maintenance for opioid dependence. Journal of Nervous and Mental Disease, 181, 358-364.
7. Leander JD (1983) Opioid agonist and antagonist behavioural effect of buprenorphine. British Journal of Pharmacology, 78, 607-615.
8. Strain EC, Stitzer ML, Liebson IA and Bigelow GE (1994) Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users. Psychopharmacology, 116, 401-406.
9. Walker EA, Butelman ER, DeCosta BR and Woods JH (1993) Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. Journal of Pharmacology and Experimental Therapeutics, 267, 280-286.
10. Walker EA, Zernig G and Woods JH (1995) Buprenorphine antagonism of mu opioids in the rhesus monkeys tail-withdrawal procedure. Journal of Pharmacology and Experimental Therapeutics, 273, 1345-1352.
11. Walsh SL, Preston KL, Bigelow GE and Stitzer ML (1995) Acute administration of buprenorphine in humans: partial agonist and blockade effects. Journal of Pharmacology and Experimental Therapeutics, 274, 361-372.
12. Winger G, Palmer RK and Woods JH (1989) Drug-reinforced responding: rapid determination of dose-response functions. Drug and Alcohol Dependence, 24, 135-142.
13. Winger G, Skjoldager P and Woods JH (1992) Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 261, 311-317.